PPBT
Income statement / Annual
Last year (2024), Purple Biotech Ltd.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, Purple Biotech Ltd.'s net income was -$7.24 M.
See Purple Biotech Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$195,804.00 |
$0.00 |
$0.00 |
$1.00 M |
$1.00 M |
$1.00 M |
$100,000.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$196,000.00
|
$120.00
|
$55.00
|
$58.00
|
$80.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$196.00
|
-$120.00
|
-$55.00
|
$999,942.00
|
$999,920.00
|
$1.00 M
|
$100,000.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
-0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
| Research and Development Expenses |
$7.62 M
|
$17.03 M
|
$16.32 M
|
$11.83 M
|
$7.49 M
|
$2.67 M
|
$5.27 M
|
$4.64 M
|
$4.18 M
|
$2.56 M
|
| General & Administrative Expenses |
$2.94 M
|
$0.00
|
$5.96 M
|
$5.82 M
|
$6.07 M
|
$6.08 M
|
$4.45 M
|
$6.39 M
|
$3.00 M
|
$1.51 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$321,000.00
|
$286,000.00
|
$235,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.94 M
|
$5.04 M
|
$6.28 M
|
$6.11 M
|
$6.31 M
|
$6.08 M
|
$4.45 M
|
$6.39 M
|
$3.00 M
|
$1.51 M
|
| Other Expenses |
$450,000.00
|
-$44.54 M
|
$0.00
|
$0.00
|
-$15.66 M
|
-$216,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.01 M
|
-$22.47 M
|
$22.60 M
|
$17.93 M
|
$13.79 M
|
$8.75 M
|
$8.83 M
|
$12.06 M
|
$7.18 M
|
$4.07 M
|
| Cost And Expenses |
$11.01 M
|
-$22.27 M
|
$22.60 M
|
$17.93 M
|
$13.79 M
|
$8.75 M
|
$8.83 M
|
$12.06 M
|
$7.18 M
|
$4.07 M
|
| Interest Income |
$260,000.00
|
$474.00
|
$969,000.00
|
$320,000.00
|
$254,000.00
|
$151,000.00
|
$93,000.00
|
$106,000.00
|
$138,000.00
|
$94,000.00
|
| Interest Expense |
$41,000.00
|
$0.00
|
$126,000.00
|
$212,000.00
|
$61,000.00
|
$181,000.00
|
$576,000.00
|
$26,000.00
|
$6,000.00
|
$3,000.00
|
| Depreciation & Amortization |
$186,000.00
|
$46,000.00
|
$49,000.00
|
$231,000.00
|
$235,000.00
|
$179,000.00
|
$7,000.00
|
$4,000.00
|
$2,000.00
|
$1,000.00
|
| EBITDA |
-$7.05 M |
-$22.23 M |
-$21.43 M |
-$17.38 M |
-$28.41 M |
-$7.64 M |
-$7.73 M |
-$11.93 M |
-$7.04 M |
-$4.20 M |
| EBITDA Ratio |
0
|
-113.51
|
0
|
0
|
-28.41
|
-7.64
|
-7.73
|
-119.29
|
0
|
0
|
| Operating Income Ratio |
0
|
113.74
|
0
|
0
|
12.61
|
-7.16
|
-7.83
|
-119.33
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.73 M
|
-$42.25 M
|
$843,000.00
|
$108,000.00
|
-$15.46 M
|
$1.96 M
|
$2.26 M
|
-$1.04 M
|
-$4.94 M
|
-$133,000.00
|
| Income Before Tax |
-$7.28 M
|
-$19.98 M
|
-$21.76 M
|
-$17.83 M
|
-$28.07 M
|
-$5.89 M
|
-$5.57 M
|
-$13.01 M
|
-$12.13 M
|
-$4.20 M
|
| Income Before Tax Ratio |
0
|
-102.03
|
0
|
0
|
-28.07
|
-5.89
|
-5.57
|
-130.08
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$877,000.00
|
$637,000.00
|
-$15.67 M
|
$216,000.00
|
$207,000.00
|
-$710,000.00
|
$6,000.00
|
-$76,000.00
|
| Net Income |
-$7.24 M
|
-$19,880.00
|
-$21.67 M
|
-$18.38 M
|
-$28.00 M
|
-$5.85 M
|
-$5.20 M
|
-$12.27 M
|
-$12.13 M
|
-$4.20 M
|
| Net Income Ratio |
0
|
-0.1
|
0
|
0
|
-28
|
-5.85
|
-5.2
|
-122.72
|
0
|
0
|
| EPS |
-0.21 |
-0.0001 |
-0.12 |
-0.1 |
-0.24 |
-0.3 |
-0.37 |
-1.3 |
-2.11 |
-4.37 |
| EPS Diluted |
-0.21 |
-0.0001 |
-0.12 |
-0.1 |
-0.16 |
-0.3 |
-0.37 |
-1.3 |
-2.11 |
-4.37 |
| Weighted Average Shares Out |
$34.65 M
|
$22.13 M
|
$18.08 M
|
$17.57 M
|
$11.50 M
|
$19.37 M
|
$14.21 M
|
$9.46 M
|
$5.76 M
|
$962,000.00
|
| Weighted Average Shares Out Diluted |
$34.65 M
|
$22.13 M
|
$18.08 M
|
$17.57 M
|
$17.18 M
|
$19.37 M
|
$14.21 M
|
$9.46 M
|
$5.76 M
|
$962,517.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
